Evidence map›Paper›PMID 32625197›Full record

ArticleFrontiers in microbiology2020

Miriam N Ojima, Aina Gotoh, Hiromi Takada, Toshitaka Odamaki, Jin-Zhong Xiao, Toshihiko Katoh, Takane Katayama

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miriam N OjimaDivision of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Aina GotohDivision of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Hiromi TakadaDivision of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Toshitaka OdamakiNext Generation Science Institute, Morinaga Milk Industry Co., Ltd., Zama, Japan.
Jin-Zhong XiaoNext Generation Science Institute, Morinaga Milk Industry Co., Ltd., Zama, Japan.
Toshihiko KatohDivision of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Takane KatayamaDivision of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiome is a dynamic community that significantly affects host health; it is frequently disturbed by medications such as antibiotics. Recently, probiotics have been proposed as a remedy for antibiotic-induced dysbiosis, but the efficacy of such treatments remains uncertain. Thus, the effect of specific antibiotic-probiotic combinations on the gut microbiome and host health warrants further research. We tested the effect vancomycin, amoxicillin, and ciprofloxacin on mice. Antibiotic administration was followed by one of the following recovery treatments:

Indexed as

antibiotic disturbanceBifidobacterium bifidumgut microbiomeprobioticsvancomycin

Identifiers

PMID32625197
PMCPMC7314955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.